TIERRA ANDERSON: Open Payments
NPI 1811379993 · TAKOMA PARK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,334 in 127 payments from 22 companies in 2025. Trend: 2023 $2,612 · 2024 $2,931 · 2025 $3,334
Food & beverage: $3,266Education: $68
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $670 |
| Amgen Inc. | 26 | $591 |
| Janssen Biotech, Inc. | 11 | $371 |
| UCB, Inc. | 8 | $259 |
| Janssen Scientific Affairs, LLC | 5 | $223 |
| Novartis Pharmaceuticals Corporation | 10 | $213 |
| AstraZeneca Pharmaceuticals LP | 3 | $172 |
| GENZYME CORPORATION | 4 | $108 |
| ANI Pharmaceuticals, Inc. | 4 | $98 |
| Radius Health, Inc. | 3 | $96 |
Products named: TREMFYA, RINVOQ, Bimzelx, KRYSTEXXA, COSENTYX, SAPHNELO, SKYRIZI, KEVZARA.
Industry payments across MD — which companies pay providers there.
